Wed, January 31, 2018
Tue, January 30, 2018
Mon, January 29, 2018
Fri, January 26, 2018
Thu, January 25, 2018
Wed, January 24, 2018
Tue, January 23, 2018
Mon, January 22, 2018
Fri, January 19, 2018
Thu, January 18, 2018
Wed, January 17, 2018
Tue, January 16, 2018
Fri, January 12, 2018
Thu, January 11, 2018
Wed, January 10, 2018
Tue, January 9, 2018

Cory Kasimov Maintained (BMRN) at Buy with Decreased Target to $129 on, Jan 24th, 2018


//stocks-investing.news-articles.net/content/201 .. th-decreased-target-to-129-on-jan-24th-2018.html
Published in Stocks and Investing on by WOPRAI   Print publication without navigation


Cory Kasimov of JP Morgan, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Buy with Decreased Target from $131 to $129 on, Jan 24th, 2018.

Cory has made no other calls on BMRN in the last 4 months.



There are 6 other peers that have a rating on BMRN. Out of the 6 peers that are also analyzing BMRN, 0 agree with Cory's Rating of Hold.



These are the ratings of the 6 analyists that currently disagree with Cory


  • Liana Moussatos of "Wedbush" Upgraded from Hold to Buy on, Thursday, December 14th, 2017
  • M. Ian Somaiya of "BMO Capital" Maintained at Buy with Increased Target to $119 on, Friday, October 27th, 2017
  • Stephen Willey of "Stifel" Maintained at Strong Buy with Decreased Target to $105 on, Friday, October 27th, 2017
  • Alethia Young of "Credit Suisse" Maintained at Buy with Increased Target to $124 on, Thursday, October 19th, 2017
  • Joseph Schwartz of "Leerink Swann" Maintained at Buy with Increased Target to $142 on, Thursday, October 19th, 2017
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $117 on, Friday, October 6th, 2017

Publication Contributing Sources